Evidence map›Paper›PMID 22420031›Full record

ArticleJournal of neuroscience research2012

N-acetyl cysteine treatment reduces mercury-induced neurotoxicity in the developing rat hippocampus.

Anthony Falluel-Morel, Lulu Lin, Katie Sokolowski, Elizabeth McCandlish, Brian Buckley, Emanuel DiCicco-Bloom

Abstract read
In one paragraph

Article in Journal of neuroscience research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Mercury Toxicity and Neurogenesis in the Mammalian Brain.International journal of molecular sciences · 2021
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. A Hypothesis and Evidence That Mercury May be an Etiological Factor in Alzheimer's Disease.International journal of environmental research and public health · 2019
    Article
  13. Article
  14. Article
  15. Neuroprotective Role ofBrain sciences · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Anthony Falluel-MorelDepartment of Neuroscience and Cell Biology, UMDNJ-Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.
Lulu Lin
Katie Sokolowski
Elizabeth McCandlish
Brian Buckley
Emanuel DiCicco-Bloom
Rutgers, The State University of New Jersey · USInserm · FRJohnson University · US

Funding

Translational Research Support CoreP30ES005022 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Debra L Laskin · 1988 to 2026
$47.4M
TRAINING IN EVIRONMENTAL TOXICOLOGYT32ES007148 · NIEHS · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI Lauren M Aleksunes · 1987 to 2026
$11.4M
NEUROTOXICANT EFFECTS ON CELL CYCLE REGULATION OF NEUROGENESISP01ES011256 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI LAMBERT, GEORGE H · 2001 to 2005
$3.3M
Perinatal Methylmercury Targets Hippocampal Stem Cells, and Reduces NeurogenesisR21ES019762 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI DICICCO-BLOOM, EMANUEL MURRAY · 2011 to 2012
$429k
Teratogenesis in the Developing HippocampusF31NS062591 · NINDS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI SOKOLOWSKI, KATIE · 2009 to 2010
$55k
NIEHS NIH HHS ES019762NIEHS NIH HHS ES05022NIEHS NIH HHS ES07148NIEHS NIH HHS ES11256NIEHS NIH HHS P01 ES011256NIEHS NIH HHS P30 ES005022NIEHS NIH HHS P30ES005022NIEHS NIH HHS R21 ES019762NIEHS NIH HHS T32 ES007148NINDS NIH HHS F31 NS062591NINDS NIH HHS NS062591
6 · The paper itself

Abstract

Mercury is an environmental toxicant that can disrupt brain development. However, although progress has been made in defining its neurotoxic effects, we know far less about available therapies that can effectively protect the brain in exposed individuals. We previously developed an animal model in which we defined the sequence of events underlying neurotoxicity: Methylmercury (MeHg) injection in postnatal rat acutely induced inhibition of mitosis and stimulated apoptosis in the hippocampus, which later resulted in intermediate-term deficits in structure size and cell number. N-acetyl cysteine (NAC) is the N-acetyl derivative of L-cysteine used clinically for treatment of drug intoxication. Here, based on its known efficacy in promoting MeHg urinary excretion, we evaluated NAC for protective effects in the developing brain. In immature neurons and precursors, MeHg (3 μM) induced a >50% decrease in DNA synthesis at 24 hr, an effect that was completely blocked by NAC coincubation. In vivo, injection of MeHg (5 μg/g bw) into 7-day-old rats induced a 22% decrease in DNA synthesis in whole hippocampus and a fourfold increase in activated caspase-3-immunoreactive cells at 24 hr and reduced total cell numbers by 13% at 3 weeks. Treatment of MeHg-exposed rats with repeated injections of NAC abolished MeHg toxicity. NAC prevented the reduction in DNA synthesis and the marked increase in caspase-3 immunoreactivity. Moreover, the intermediate-term decrease in hippocampal cell number provoked by MeHg was fully blocked by NAC. Altogether these results suggest that MeHg toxicity in the perinatal brain can be ameliorated by using NAC, opening potential avenues for therapeutic intervention.

Indexed as

HippocampusAcetylcysteineAnalysis of VarianceAnimalsAnimals, NewbornCell DeathCells, CulturedCerebral CortexDisease Models, AnimalDose-Response Relationship, DrugEmbryo, MammalianFemaleMaleMethylmercury CompoundsNeuronsNeuroprotective AgentsAcetylcysteinemethylmercuric chlorideMethylmercury CompoundsNeuroprotective AgentsThymidineTritium

Identifiers

PMID22420031
PMCPMC3306130
OpenAlexW2110446196

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.